Enzalutamide With Lu PSMA-617 Versus Enzalutamide Alone in Men With Metastatic Castration-resistant Prostate Cancer

Condition:   Metastatic Castration-Resistant Prostate Cancer Interventions:   Drug: Lu-PSMA;   Drug: Enzalutamide Sponsors:   Australian and New Zealand Urogenital and Prostate Cancer Trials Group;   National Health and Medical Research Council, Clinical Trials Centre;   Prostate Cancer Research Alliance;   Endocyte;   Astellas Pharma Inc;   Australian Nuclear Science and Technology Organisation Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials